EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

05.12.18

The EPO’s ‘Inventor Award’ Scam: Part II

Posted in Deception, Europe, Patents at 12:08 am by Dr. Roy Schestowitz

Andane Remmal

Summary: The sorts of people whom Battistelli’s EPO grants awards to are sometimes literal frauds and sometimes people who, according to domain experts, did not even deserve the patent they got a prize for

THE EPO is a highly abusive organisation. We’d go further and say corrupt, albeit that typically leads the EPO to trying to SLAPP us. We have never ever seen anything remotely like it at the USPTO, which is reasonably professional. We focus on patent scope there (this has improved in recent years). The USPTO maintains neutrality on patents; no rankings or “awards” (a form of special endorsement)…

EPO insiders can’t stop talking about next month’s event, which will be the passage of EPO budget to Saint-Germain-en-Laye.

As one comment put it a couple of days ago: “Hadn’t you noticed that the EPO is currently under the – I am almost tempted to add “totalitarian” – political control of the deputy mayor of Saint-Germain-en-Laye?”

Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…

“Does nobody in the mainstream media see the problem with that? It’s not only against the rules (for public servants in international institutions); putting aside the passage of EPO money to Saint-Germain-en-Laye…”The remark is in the fifth comment by the way, responding to “MaxDrei” (mentioned/quoted here in relation to its context).

But this post is not about the scandal of Battistelli’s ‘alleged’ misuse of budget or even the award to a literal fraud (whom the EPO now tries to distance itself from — very, very belatedly). This post relates to our first part, which spoke about Morocco, a former French colony which Battistelli seems to be oftentimes leveraging for political agenda. This post is about award for EP1879655B1 (“Advanced [sic] Scientific [sic] Developments” [sic] led by Mr. Remmal).

How much of an invention was it really? Someone who is familiar with this scientific domain looked more closely at it. I should disclose that it’s well outside my field of specialty, so I mostly rely on others for this assessment, which was carried out anonymously.

“How much of an invention was it really?”“It is about the mentioned patent granted to Remmal,” told us a source, “who got the EPO inventor award last year.

“In my opinion there was a lot ado about nothing in the Gazette.”

There was an article about it the Gazette, in French even! [Page 1, Page 2]

“In the present case I am not questioning the probity of Mr. Remmal,” our source said, “but he is definitely NOT the genius that the EPO makes out of him.

“Clinical phytotherapy is a research field since the early 70s. Synergistic effects were investigated with antibiotics alone, and are the basis of aromatherapy. Yet the combination of essential oils and antibiotics and corresponding synergistic effects have been disclosed in 2003 already. See this publication: Bacterial resistance modifying agents from Lycopus europaeus.”

From the Abstract: “As part of an ongoing project to identify plant natural products which modulate bacterial multidrug resistance (MDR), bioassay-guided isolation of an extract of Lycopus europaeus yielded two new isopimarane diterpenes, namely methyl-1alpha-acetoxy-7alpha 14alpha-dihydroxy-8,15-isopimaradien-18-oate (1) and methyl-1alpha,14alpha-diacetoxy-7alpha-hydroxy-8,15-isopimaradien-18-oate (2). The structures were established by spectroscopic methods. These compounds and several known diterpenes were tested for in vitro antibacterial and resistance modifying activity against strains of Staphylococcus aureus possessing the Tet(K), Msr(A), and Nor(A) multidrug resistance efflux mechanisms. At 512 microg/ml none of the compounds displayed any antibacterial activity but individually in combination with tetracycline and erythromycin, a two-fold potentiation of the activities of these antibiotics was observed against two strains of S. aureus that were highly resistant to these agents due to the presence of the multidrug efflux mechanisms Tet(K) (tetracycline resistance) and Msr(A) (macrolide resistance).

Our source continued to stress “that predates the priority date. (2005). Note that this document wasn’t cited – unfortunately – in the search report. This document does not quote carvacrol, carveol or alpha-ionone as constituents of essential oils. But carvacrol and carveol were already known at that time for their antibiotic effect . I see no inventive step there. In my opinion the inventor of the year 2017 was awarded a prize on the basis of an unduly granted patent.”

Research into this has gone on for at least a week. It’s not a rushed judgment. As our source put it, having consulted others as well, “the more I look into the Remmal case, the more I believe we have explosive material. I had the document I referred to double-checked by a specialist and yes I can say that the granted claims do not have the required inventive step.

“But there is more than that. The company owned by Mr.Remmal, Advanced Scientific Developments, is an asset management firm (gestion de valeur mobilere).”

On the day of the priority date (13/5/2005) Mr. Remmal filed 4 applications, namely:

  • US20080171709A1: Pharmaceutical composition comprising an antiviral agent, an antitumoral agent or an anti-parasitic agent, and active agent selected among carveol, thymol, eugenol, borneol and carvacrol.
  • US20080214568A1: pharmaceutical combination comprising an antifungal agent and an active substance selected from carveol, eugenol, thymol, borneol, carvacrol, and alpha- and beta-ionones.
  • US20080171768A1: pharmaceutical composition containing an anti-parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone.
  • US20080214518A1: pharmaceutical composition comprising an antibacterial agent and an active ingredient selected from carveol, thymol, eugenol, borneol and carvacrol.

“The last one in its EPO version is the patent on which Remmal received the “inventor” award,” our source remarked. “On all 4 patents the addition of essential oils exhibits a notable synergistic effect, not only with antibiotics but also with antifungal, anti-parasitic, anti-tumoral, antiviral agents. If all this was true, Mr. Remmal would deserve a Nobel prize, not just a dubious EPO inventor award prize.”

“I have also checked the publications by Remmal,” the source noted. “The number and scope of the publications is an indicator of a scientist’s activity. Here is a list. What I see are many publications in the field of essential oils and their medical uses. All these papers are published by Remmal at al but none deals with the use of essential oils in combination with other medications. I find very awkward that none of the publications addresses the subject for which the EP patent was applied for.

“To close the subject, an article published just after Mr. Remmal was awarded the EPO inventor prize [is] a very touching article that looks more like self promotion. I don’t want to judge someone without having an in-depth knowledge of the situation, but considering all the facts I have made my opinion and it is not positive. Frankly, I believe that Remmal is just another troll. What do you think?”

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 18/7/2018: System76's Manufacturing Facility, Microsoft-Led Lobby for Antitrust Against Android

    Links for the day



  2. What Patent Lawyers Aren't Saying: Most Patent Litigation Has Become Too Risky to be Worth It

    The lawyers' key to the castle is lost or misplaced; they can't quite find/obtain leverage in courts, but they don't want their clients to know that



  3. Software Patents Royalty (Tax) Campaign by IBM, a Serial Patent Bully, and the EPO's Participation in All This

    The agenda of US-based patent maximalists, including patent trolls and notorious bullies from the United States, is still being served by the 'European' Patent Office, which has already outsourced some of its work (e.g. translations, PR, surveillance) to the US



  4. The European Council Needs to Check Battistelli's Back Room Deals/Back Door/Backchannel With Respect to Christian Archambeau

    Worries persist that Archambeau is about to become an unworthy beneficiary (nepotism) after a Battistelli setup that put Campinos in power, supported by the Belgian delegation which is connected to Archambeau, a national/citizen of Belgium



  5. PTAB and § 101 (Section 101) Have Locked the Patent Parasites Out of the Patent System

    Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs) have contributed a great deal to patent quality and have reduced the number of frivolous patent lawsuits; this means that firms which profit from patent applications and litigation hate it with a passion and still lobby to weaken if not scuttle PTAB



  6. Patents on Computer Software and Plants in the United States Indicative of Systemic Error

    The never-ending expansion of patent scope has meant that patent law firms generally got their way at the patent office; can the courts react fast enough (before confidence in patents and/or public support for patents is altogether shattered)?



  7. Yesterday's Misleading News From Team UPC and Its Aspiring Management of the Unified Patent Court (UPC)

    The Unified Patent Court (UPC) enthusiasts — i.e. those looking to financially gain from it — continue to wrestle with logic, manipulate words and misrepresent the law; yesterday we saw many law firms trying to make it sound as though the UPC is coming to the UK even though this isn’t possible and UPC as a whole is likely already dead



  8. Time for the European Commission to Investigate EPO Corruption Because It May be Partly or Indirectly Connected to EU-IPO, an EU Agency

    The passage of the top role at the EU-IPO from António Campinos to Christian Archambeau would damage confidence in the moral integrity of the European Council; back room deals are alleged to have occurred, implicating corrupt Battistelli



  9. Links 17/7/2018: Catfish 1.4.6 Released, ReactOS 0.4.9, Red Hat's GPL Compliance Group Grows

    Links for the day



  10. Links 16/7/2018: Linux 4.18 RC5, Latte Dock v0.8, Windows Back Doors Resurface

    Links for the day



  11. Alliance for US Startups and Inventors for Jobs (USIJ) Misleads the US Government, Pretending to Speak for Startups While Spreading Lies for the Patent Microcosm

    In the United States, which nowadays strives to raise the patent bar, the House Small Business Committee heard from technology firms but it also heard from some questionable front groups which claim to support "startups" and "jobs" (but in reality support just patents on the face of it)



  12. 'Blockchain', 'Cloud' and Whatever Else Gets Exploited to Work Around 35 U.S.C. § 101 (or the EPC) and Patent Algorithms/Software

    Looking for a quick buck or some low-quality patents (which courts would almost certainly reject), opportunists carry on with their gold rush, aided by buzzwords and hype over pretty meaningless things



  13. PTAB Defended by the EFF, the R Street Institute and CCIA as the Number of Petitions (IPRs) Continues to Grow

    Patent Trial and Appeal Board (PTAB) inter partes reviews (IPRs) come to the rescue when patently-bogus patents are used, covering totally abstract concepts (like software patents do); IPRs continue to increase in number and opponents of PTAB, who conveniently cherry-pick Supreme Court (SCOTUS) decisions, can't quite stop that



  14. IAM/Joff Wild May Have Become a de Facto Media Partner of the Patent Troll iPEL

    Invitation to trolls in China, courtesy of the patent trolls' lobby called "IAM"; this shows no signs of stopping and has become rather blatant



  15. Cautionary Tale: ILO Administrative Tribunal Cases (Appeals) 'Intercepted' Under António Campinos

    The ILO Administrative Tribunal (ILO-AT) is advertised by the EPO's management as access to justice, but it's still being undermined quite severely to the detriment of aggrieved staff



  16. Asking the USPTO to Comply With 35 U.S.C. § 101 is Like Asking Pentagon Officials to Pursue Real, Persistent Peace

    Some profit from selling weapons, whereas others profit from patent grants and litigation; what's really needed right now is patent sanity and adherence to the public interest as well as the law itself, e.g. Supreme Court (SCOTUS) decisions



  17. BT and Sonos Are Still Patent Bullies, Seeing Patents as a Backup Plan

    The companies seeking to complement their business (or make up for their demise) using patents are still suing rivals while calling that litigation "research and development" (the same old euphemism)



  18. Jim Skippen, a Longtime Patent Troll, Admits That the Trolling Sector is Collapsing

    Canada's biggest patent troll (WiLAN) bar BlackBerry doesn't seem to be doing too well as its CEO leaves the domain altogether



  19. From East Asia to the Eastern District of Texas: XYZ Printing, Maxell, and X2Y Attenuators

    The patent aggression, which relies on improper litigation venues, harms innocent parties a great deal; only their lawyers benefit from all this mess



  20. Links 14/7/2018: Mesa 18.1.4, Elisa 0.2.1, More on Python's Guido van Rossum

    Links for the day



  21. Number of Oppositions to Grants/Awards of European Patents at the EPO Has Skyrocketed, Based on Internal Data

    The number of challenged patents continues to soar and staff of the EPO (examiners already over-encumbered by far too much work, due to unrealistic targets) would struggle to cope or simply be compelled to not properly deal with oppositions



  22. 'Transaction' Complete: Former EPO Executive From Belgium Takes the Seat of António Campinos at EU-IPO

    Rumours that Belgium made a back room deal with Battistelli may be further substantiated with the just-confirmed appointment of Archambeau



  23. EPO Abuses Against People With Disabilities Followed by Legal Bullying?

    The new President of the EPO is not (at least not yet) obeying court rulings from ILO; The above move seems like an attempt to derail ongoing cases at the ILO’s Administrative Tribunal (ILO-AT), i.e. yet more strong-arming



  24. Weeks Later António Campinos Still in Noncompliance With the Courts (ILO's Tribunal)

    'report card' for the ever-so-intransparent (or nontransparent) new President of the EPO, who does not even bother obeying court rulings



  25. Links 13/7/2018: Kube 0.7.0, Trisquel 8.0 LTS Reviewed

    Links for the day



  26. Constitutionality and CJEU as Barriers, the UPC Agreement (UPCA) is Already Moot in the United Kingdom

    The Unified Patent Court (UPC) isn't going anywhere and the UK merely "explores" what to do about it; for Team UPC, however, this means that the UK "confirms intention to remain in Unitary Patent system after Brexit" (clearly a case of deliberate misinformation)



  27. It's Not About EPO 'Backlog' But About Faking 'Production' by Lowering Standards

    Remarks on the EPO dropping all pretenses of genuine care for patent quality; it's all about speed now, never mind if wrongly-granted patents can cause billions in damages across Europe (a lot of that money flows towards patent law firms)



  28. Links 12/7/2018: GTK+ 4.0 Plans, OpenBSD Gains Wi-Fi “Auto-Join”

    Links for the day



  29. The Anti-35 U.S.C. § 101 Lobby Pushes Old News Into the Headlines in an Effort to Resurrect/Protect Software Patents

    The software patenting proponents (law firms for the most part) are still doing anything they can -- stretching even months into the past -- in an effort to modify the law in defiance of Supreme Court (SCOTUS) rulings



  30. Thomas Massie and Marcy Kaptur Are Promoting the Interests of Patent Trolls and Patent Lawyers While Calling That “Innovation”

    Remarks on the ongoing effort to promote patent trolls’ interests under the guise of “helping small businesses” — a very misleading propaganda pattern that we have been finding in Unified Patent Court (UPC) lobbying at the EPO


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts